HYbrid RObotic Surgery MulTiCentric Study
HYROS-MTC-I
1 other identifier
interventional
50
1 country
5
Brief Summary
The purpose of this clinical investigation, HYROS-MTC-I, is to confirm the effectiveness of the combined use of ROB-Bitrack System, its corresponding ElectroSurgical Endoscopic instruments and Non-ElectroSurgical Endoscopic instruments (ESE and NESE instruments respectively) and accessories in a multicentric study in urologic procedures with the indication of a robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy (PN), Radical Prostatectomy (RP or P), and when it applies Lysis of Adhesions (during a PN, RN or RP or P to cut the adhesions and reach the organ) and Lymphadenectomy (only after a P with the aim to remove the lymph nodes) . HYROS-MTC-I is a confirmatory study in which the hypothesis of the primary endpoint is that: "Operative time (OT) with Bitrack System and its ESE/NESE Instruments and accessories will be equal or lower than superiority margin time of State of the Art (SoTA) of MIRS (Minimally Invasive Robotic Surgery) independently of the user experience and site". This study includes the data collected up to 30 days post-surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2025
CompletedStudy Start
First participant enrolled
January 15, 2025
CompletedFirst Posted
Study publicly available on registry
February 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJuly 31, 2025
July 1, 2025
10 months
January 9, 2025
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Operative time (OT) with ROB-Bitrack System and its ESE/NESE Instruments and accessories to perform the surgeries.
Evaluation of Operative time from first skin incision to last skin suture of the procedure.It is hypothesized that Operative time (OT) will be equal or lower than the maximum time as defined by the State of the Art (SoTA) of MIRS independently of the user experience and site.
During the procedure
Study Arms (1)
Patients surgically treated with ROB-Bitrack System and ESE/ NESE instruments and accessories
EXPERIMENTALInterventions
Complete remove of the kidney. In addition as part of the intervention, a procedure termed "Lysis of abdominal adhesions" may be performed according to patient medical condition and/or surgeon criteria.
Partial remove of a section in the kidney. In addition, as part of the intervention, a procedure termed "Lysis of abdominal adhesions" may be performed according to patient medical condition and/or surgeon criteria.
Complete remove of the prostate gland. In addition as part of the intervention, two procedures termed "Lysis of abdominal adhesions" and/or "Lymphadenectomy " (removal of regional lymph nodes) may be performed according to patient medical condition and/or surgeon criteria.
Eligibility Criteria
You may qualify if:
- Adult subjects between 18 and 90 years old who have provided written informed consent prior to any clinical investigation related procedures.
- Subjects who have been scheduled for a laparoscopic Radical/simple Nephrectomy surgery, laparoscopic Partial Nephrectomy or laparoscopic Radical Prostatectomy following the surgeon criteria.
- Ability and willingness to comply with all study requirements to be evaluated for each study visit.
You may not qualify if:
- Pregnant or breastfeeding women at the time of the surgery.
- Subjects with severe concomitant illness that, at PrincipaI investigator´s discretion, increases risk of therapeutic interventions or that have been submitted to multiple prior surgeries.
- Subjects admitted to the hospital due to an emergency situation.
- Subjects with untreated active infection.
- Subject with known allergy to some of the device components (i.e., stainless steel, etc.)
- Subjects not suitable to undergo Minimally Invasive Surgery (MIS)/ Minimally Invasive Robotic Surgery (MIRS), according to medical criteria.
- Subjects with life expectancy inferior to 3 months.
- Subjects with a BMI (Body Mass Index) ≥ 40
- Subjects with any contraindication for the use of the ROB-Bitrack System and the ESE/NESE instruments, as specified in the Instructions For Use.
- Subjects with abuses of active substances or with uncontrolled psychiatric disorders.
- Subjects with severe cardiopulmonary or coronary artery disease, bleeding disorders or that have been submitted to multiple prior operations.
- Subjects scheduled for surgeries intended to be in direct contact with the heart, the central circulatory system or the central nervous system.
- Inability to adhere to study-related procedures.
- Subjects who participate in another trial which may affect the outcome data on this study or the ability to complete the follow up requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Hospital del Mar
Barcelona, Spain, 08003, Spain
Hospital Clinic de Barcelona
Barcelona, Spain, 08036, Spain
Hospital General de Granollers
Granollers, Spain, 08402, Spain
Hospital de Mataró
Mataró, Spain, 08304, Spain
Hospital Universitari de Vic
Vic, Spain, 08500, Spain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2025
First Posted
February 27, 2025
Study Start
January 15, 2025
Primary Completion
November 1, 2025
Study Completion
December 1, 2025
Last Updated
July 31, 2025
Record last verified: 2025-07